Philippines condemns China's rocket launch after suspected debris sparked alarm
There were no immediate reports of injuries or damage from the suspected Chinese rocket debris that fell near Palawan province Monday night, National Security Adviser Eduardo Año said. However, he added that these posed 'a clear danger and risk to land areas and to ships, aircraft, fishing boats and other vessels' near the expected drop zones.
'We condemn in no uncertain terms the irresponsible testing done by the People's Republic of China of its Long March 12 rocket which alarmed the public and placed the people of Palawan at risk,' Año said in a statement.
People were alarmed after hearing loud explosions Monday night in Palawan's Puerto Princesa city and nearby towns, Año said, adding that 'local residents also saw a fireball cross the sky that later exploded causing the ground to shake.'
Chinese officials did not immediately comment on Año's statement.
China's official Xinhua News Agency reported that the Long March-12 rocket that lifted off Monday night from a commercial spacecraft launch site on the southern island province of Hainan successfully carried a group of internet satellites into pre-set orbit. It was the 587th mission by the Long March carrier rockets, Xinhua said, citing the launch site.
It was not immediately clear if Chinese authorities notified nearby countries like the Philippines of possible debris from its latest rocket launch.
The Philippine Space Agency said Monday that debris from the rocket launch was expected to have fallen within two identified drop zones about 21 nautical miles (39 kilometers) from Puerto Princesa City in Palawan and 18 nautical miles (33 kilometers) from Tubbataha Reef Natural Park, an area of coral reefs in the Sulu Sea off eastern Palawan that is popular among divers and conservators.
'Unburned debris from rockets, such as the booster and fairing, are designed to be discarded as the rocket enters outer space,' the space agency said. 'While not projected to fall on land features or inhabited areas, falling debris poses danger and potential risk to ships, aircraft, fishing boats and other vessels that will pass through the drop zone.'
Philippine aircraft and vessels were deployed Tuesday to search for the rocket debris, Año said. He asked the public to notify authorities if they find any piece of debris but warned them not to touch them because of possible toxic fuel residues.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Politico
2 hours ago
- Politico
Space Race 2.0
With help from Connor O'Brien and Alex Nieves WELCOME TO POLITICO PRO SPACE. NASA interim administrator Sean Duffy made a splash this week with his first directives at the agency, including advancing plans for a nuclear reactor on the moon. What's your opinion of the new administrator? Should President Donald Trump just keep him in the post or continue the search for a permanent head? Email me at sskove@ with tips, pitches and feedback, and find me on X at @samuelskove. And remember, we're offering this newsletter for free over the next few weeks. After that, only POLITICO Pro subscribers will receive it. Read all about it. The Spotlight The Pentagon has poured millions of dollars into preparing for a threat from Beijing on land and at sea. But U.S. officials increasingly worry they're missing the chance to tackle another big risk: China in space. Rep. Brian Babin (R-Texas), chair of the committee that oversees NASA, warned this week that American astronauts might land on the moon and be greeted by a 'no trespassing' sign in Mandarin if the U.S. doesn't step up. Some of the rhetoric is akin to orbital debris. But the U.S. does face challenges from China in both military and commercial space. Beijing could weaponize satellites and other tools to prevent the U.S. from helping Taiwan — or anyone else — in a conflict. And if the Chinese government plants a flag on the moon, it could bar American access to lucrative new resources on the lunar surface. China ascendant: Beijing is second only to America in its vast array of space capabilities, according to Chinese space expert Blaine Curcio. And, in some cases, it now surpasses the U.S. For example, China in July attempted the first-ever satellite refueling in orbit. China is also figuring out how to knock out satellites that allow the U.S. to communicate in the Pacific, said Dean Cheng, a nonresident fellow at the Space Policy Institute. 'The Chinese have been very carefully and assiduously developing an array of military counter space options.' But the commercial use of many space tools makes it harder to figure out what's actually a threat. Chinese satellites that can move debris, for instance, may also be able to eviscerate an American satellite. 'China isn't big on transparency,' said Victoria Samson, a space expert at the Secure World Foundation, a space-focused think tank. Moon dance: China also has plans to land an astronaut on the moon by 2030 and set up a permanent base. Such a move would dent American prestige, as it would no longer be the only nation to land on the lunar surface. It would also allow Beijing to write the terms for potentially lucrative space exploration. 'We're in a race to the moon, in a race with China to the moon,' Duffy said Tuesday at a press conference. China already has shown it can pull off complex uncrewed lunar missions. Beijing recently used its Chang'e 6 to land a rover on the moon and return samples to Earth. The U.S. aims to return to the lunar surface in 2027, before China gets there. But the timeline has slipped before due to spacecraft issues, and it could happen again. Room for hope: Beijing has been less successful when it comes to the commercial sector, which the U.S. dominates. Think reusable rockets and low-earth satellite constellations such as Starlink. This is despite the Chinese government's effort to supercharge the growth of a commercial space sector through investments and other support, such as free land or factory space. But so far, there are more companies than space services. 'You have this absence of real demand,' Curcio said. 'And then you've also had all this government money coming in and creating oversupply in some situations.' The high number of companies may also dilute the ability of any single firm since they're competing for the same specialized engineering talent, he said. 'You're not going to really have a critical mass of highly talented rocket scientists working for any one company.' Galactic Government SpaceX vs. California: The fight between Elon Musk's SpaceX and the California agency tasked with protecting the state's coastline is back on. Space Force officials will stand in front of the California Coastal Commission next week with a plan to double the company's rocket launches from Vandenberg Space Force Base from 50 to 95 per year. And the agency staff is recommending commissioners reject it. 'The simple fact remains that it is a privately owned company engaged in activities primarily for its own commercial business,' staff said in a Friday report. 'It is not a public federal agency or conducting its launches on behalf of the federal government.' That argument mirrors commissioners' pushback in October when they rejected an increase from 36 to 50 launches. SpaceX sued the agency for bias after members cited Musk's politics. Space Force ultimately moved forward with the increase, citing federal preemption and national security considerations. SpaceX did not respond to a request for comment. Space Launch Delta 30 Commander Col. James T. Horne III, who oversees Vandenberg and Western operations, noted the military's 'unwavering commitment to preserving the California coastline' and said its partnership with SpaceX allows the agency to maintain 'its technological edge and strategic advantage over competitors.' Military SPACE FORCE GETS NEW NO. 2: The Space Force has a new no. 2 officer on the job. The Senate quietly approved Gen. Shawn Bratton for vice chief of space operations last week and promoted him to a four-star general before leaving town until September. He officially took over on July 31, the same day he was confirmed. Bratton succeeds Gen. Michael Guetlein, who was approved in July to oversee the nascent — and nebulous — Golden Dome missile defense shield. Bratton was most recently the Space Force's deputy chief for strategy, plans, programs and requirements. That made him a key player in the development of the recently released Space Warfighting Framework, the service's blueprint for how it would conduct war in space. He was also the first commander of the Space Training and Readiness Command, which leads training for the Space Force. He began his military career as an enlisted member of the Arizona Air National Guard. Bratton was part of a larger tranche of officers whose promotions were confirmed before the Senate recessed. The Reading Room At missile defense conference, the first rule of Golden Dome is don't talk about Golden Dome: Breaking Defense SpaceX signs deal to fly Italian experiments to Mars on Starship's 1st commercial Red Planet flights: New report details Trump DoD's space spending spree: Payload NASA's new chief has radically rewritten the rules for private space stations: Ars Technica Firefly Aerospace Surges 45% After Upsized $868 Million IPO: Bloomberg Duffy to announce nuclear reactor on the moon: POLITICO Event Horizon SUNDAY: The 39th Annual Small Satellite Conference begins. Photo of the Week
Yahoo
19 hours ago
- Yahoo
China's clinical trial ecosystem takes centre stage in Suzhou this September
China's rapid emergence as a global clinical trials powerhouse will be in sharp focus this September as leading voices from the biopharma and healthcare sectors convene in Suzhou for the launch of Outsourcing in Clinical Trials China and Clinical Trial Supply China. Held over two days on 3-4 September 2025, the dual event brings together senior executives, regulators, and innovators across R&D, clinical operations, outsourcing, and supply chain to examine the evolving landscape of clinical development in China - arguably the world's most dynamic biopharma market. Strategic inflection point China's clinical trials sector has undergone significant structural transformation over the past five years, driven by a combination of regulatory shifts, capital inflows into biotech, and a shift toward more decentralised, patient-centric trial models. According to GlobalData analysis, China now surpasses the US for annual number of clinical trials. Yet as the ecosystem expands, so too does its complexity - particularly in relation to cross-border compliance, data protection, and clinical logistics. This new industry event marks a pivotal moment, featuring an opening keynote panel on 'The Evolving Clinical Trial Landscape in China: Challenges & Opportunities,' alongside in-depth discussions on artificial intelligence in drug discovery, clinical supply chain management, and geopolitical risk. Sessions will span core operational challenges - including site selection, enhancing collaboration in outsourcing, comparator sourcing, cold chain logistics, and vendor management - as well as broader questions on global collaboration, clinical trial harmonisation, and China's biotech ambitions. The program includes a panel on 'The Rise of Chinese Biotech: A Competitive Challenge for US Companies and Investors,' reflecting growing interest in China's ability to scale R&D innovation, supported by state policy and venture capital. While China continues to make strides in drug discovery and innovation, integration into the global clinical development ecosystem remains uneven. Concerns around IP protection, regulatory uncertainty, and data localisation persist, particularly for international sponsors managing multi-country trials. Speakers from IDA Ireland, Singapore's Agency for Science, Technology and Research, and the US Maryland China Center will participate in a cross-border panel addressing the impact of China's biotech boom on global trials. On 4 September, delegates will have the opportunity to participate in a curated site visit to Biobay, the national biomedical innovation zone located in Suzhou Industrial Park. The tour includes direct engagement with local biotech executives and exposure to platform technologies shaping the next wave of drug development. Confirmed speakers include: Li Zeng, CEO, Jing Medicine Summer Xia, CEO, Trial-Data Medicine Vincent Zang, Senior Director, Clinical Trial Operation, Innovent Bio Angela Yu, Head of Outsourcing, East China Pharm Shen Xiao, CMO, Alebund Siwei Li, Director, Drug Metabolism and Pharmacokinetics, Degron Therapeutics Xiaoyu Deng, Founder, MDCE Medical Megan Qin, Head of Medical Device Clinical Excellence Working Group, CMAC Xiaoyu Deng, Founder, MDCE Medical Claire Qin, Chief Strategy Officer, Intelligen AI Min Geng, Head of Supply Chain, Shanghai Pharma Fiona Barry, Editor in Chief & Director, Globaldata Healthcare Shelly Xie，Associate Director, Clinical & QC Management,Eli Lilly Jinna Qin, President, China Association for Vaccines Daniel Gao, President, ISPE Supply Chain Committee Xiaomei Wang, VP of Clinical Trial Operation, Key Therapharma Yugang Ju, Head of Clinical Operation, Insilico Medicine Quancheng Chen, Agency for Science, Technology and Research, Singapore Chester Xiao, Head of Life Science Industry, IDA Ireland Vikki Wang, Head of China Center, U.S. Maryland China Center View the full list of speakers and the complete conference agenda here. Don't miss this exclusive opportunity to connect with industry leaders, gain actionable insights, and stay ahead in the rapidly evolving clinical trials landscape in China. Join the Outsourcing in Clinical Trials China & Clinical Trial Supply China, happening 3-4 September at the Renaissance Suzhou Hotel. Register here: "China's clinical trial ecosystem takes centre stage in Suzhou this September" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
San Francisco Chronicle
19 hours ago
- San Francisco Chronicle
Hubble Space Telescope takes best picture yet of the comet visiting from another solar system
CAPE CANAVERAL, Fla. (AP) — The Hubble Space Telescope has captured the best picture yet of a high-speed comet visiting our solar system from another star. NASA and the European Space Agency released the latest photos Thursday. Discovered last month by a telescope in Chile, the comet known as 3I-Atlas is only the third known interstellar object to pass our way and poses no threat to Earth. Astronomers originally estimated the size of its icy core at several miles (tens of kilometers) across, but Hubble's observations have narrowed it down to no more than 3.5 miles (5.6 kilometers). It could even be as small as 1,000 feet (320 meters), according to scientists. The comet is hurtling our way at 130,000 mph (209,000 kph), but will veer closer to Mars than Earth, keeping a safe distance from both. It was 277 million miles (446 million kilometers) away when photographed by Hubble a couple weeks ago. The orbiting telescope revealed a teardrop-shaped plume of dust around the nucleus as well as traces of a dusty tail. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
